COST EFFECTIVENESS ANALYSIS COMPARING ENZALUTAMIDE, ABIRATERONE PLUS PREDNISONE AND CABAZITAXEL PLUS PREDINSONE FOR THE TREATMENT OF VISCERAL METASTATIC CASTRATION RESISTANT PROSTATE CANCER (MCRPC) POST DOCETAXEL FAILURE

被引:0
作者
Barqawi, Y. [1 ]
Borrego, M. [1 ]
Roberts, M. [1 ]
Abraham, I [2 ]
机构
[1] Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA
[2] Univ Arizona, Coll Pharm, Ctr Hlth Outcomes & PharmacoEcon Res, Tucson, AZ 85721 USA
关键词
D O I
10.1016/j.jval.2019.04.225
中图分类号
F [经济];
学科分类号
02 ;
摘要
PCN101
引用
收藏
页码:S75 / S75
页数:1
相关论文
empty
未找到相关数据